Implantable biomaterials having functional surfaces

US10314949B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10314949-B2
Application numberUS-201816047297-A
CountryUS
Kind codeB2
Filing dateJul 27, 2018
Priority dateSep 26, 2002
Publication dateJun 11, 2019
Grant dateJun 11, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Implantable materials having defined patterns of affinity regions for binding endothelial cells and providing for directed endothelial cell migration across the surface of the material. The affinity regions include photochemically altered regions of a material surface and physical members patterned on the material surface that exhibit a greater affinity for endothelial cell binding and migration than the remaining regions of the material surface.

First claim

Opening claim text (preview).

What is claimed is: 1. An implantable medical device made from a biocompatible material, the biocompatible material forming at least one surface of the implantable medical device, the at least one surface of the biocompatible material further having a patterned array of functional features on the at least one surface of the biocompatible material, wherein each of functional features has a surface energy higher than a surface energy of a remainder of the at least one surface of the biomaterial, and wherein the patterned array of functional features has a spacing between adjacent functional features configured to promote cell propagation between adjacent functional features and along the at least one surface of the implantable medical device. 2. The implantable medical device of claim 1 , wherein the spacing between adjacent functional features is between about 10 μm to about 75 μm. 3. The implantable medical device according to claim 1 , wherein each of the functional features further comprises photochemically altered regions of the biocompatible material. 4. The implantable medical device according to claim 3 , wherein each of the photochemically altered regions further comprises a titanium oxide. 5. The implantable medical device according to claim 1 , wherein the biocompatible material further comprises a component made from nickel-titanium alloy. 6. The implantable medical device according to claim 1 , wherein each of the functional features is nickel-titanium alloy. 7. The implantable medical device according to claim 1 , wherein each of the functional features comprises a focal adhesion point for affinity binding of endothelial cells. 8. The implantable medical device according to claim 7 , wherein each of the focal adhesion points has a binding affinity for endothelial cells that is greater than a binding affinity of the native implantable biomaterial. 9. An implantable biomaterial having at least one surface thereof that comprises the biomaterial and a defined pattern of a plurality of functional features having a height above the at least one surface greater than 0μ, each of the plurality functional features having a greater endothelial cell binding affinity greater than an endothelial cell binding affinity of the biomaterial, wherein each of the functional features further comprise photochemically altered regions of the biocompatible material. 10. The implantable biomaterial according to claim 9 , wherein the functional features have a height between greater than 0 μ to about 3.0 μ. 11. The implantable biomaterial according to claim 9 , wherein each of the functional features comprises a focal adhesion point for affinity binding of endothelial cells. 12. The implantable biomaterial according to claim 9 , wherein each of the functional features has a width between about 10 μm to about 75 μm. 13. The implantable biomaterial according to claim 9 , further comprising a gap distance between adjacent functional features between about 10 μm to about 75 μm.

Assignees

Inventors

Classifications

  • A61L31/028Primary

    Other inorganic materials not covered by A61L31/022 - A61L31/026 · CPC title

  • for preferentially controlling or promoting the growth of specific types of cells or tissues · CPC title

  • Prostheses implantable into the body · CPC title

  • Special surfaces of prostheses, e.g. for improving ingrowth (A61F2/30767 takes precedence) · CPC title

  • A61F2/00Primary

    Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (dental prostheses A61C13/00; artificial kidneys A61M1/14; artificial hearts A61M60/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10314949B2 cover?
Implantable materials having defined patterns of affinity regions for binding endothelial cells and providing for directed endothelial cell migration across the surface of the material. The affinity regions include photochemically altered regions of a material surface and physical members patterned on the material surface that exhibit a greater affinity for endothelial cell binding and migratio…
Who is the assignee on this patent?
Vactronix Scientific Llc
What technology area does this patent fall under?
Primary CPC classification A61L31/028. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).